Skip to main content
OpenTrials
Completed

NCT Number: NCT05772988

Beta-alanine Supplementation and CrossFit Performance

This study will randomize CrossFit participants to receive beta-alanine or placebo supplementation for 3 weeks. The study will be double-blind. Performance on the "Fran" test will be completed at baseline and after the 3 week intervention. Respiratory exchange ratio will also be assessed during the performance test at baseline and after 3 weeks.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Saskatchewan

Saskatoon, Saskatchewan, S7N5B2, Canada

About this study

Beta-alanine is a nutritional supplement often consumed by people involved in high-intensity sports that involve substantial lactic acidosis. If consumed on a regular basis, it improves muscle buffering capacity and exercise performance during high-intensity moderate-duration events. CrossFit involves competitions that are high in intensity and moderate duration and many elite CrossFit athletes have reported taking beta-alanine as a supplement. It has never however been evaluated in a research study for its affect on CrossFit performance. The purpose of the study is therefore to assess the effects of beta-alanine supplementation on CrossFit performance. A maximum of 30 CrossFit participants will participate in this randomized double-blind parallel groups study. Participants will be randomized to receive 6.4 g/d beta-alanine or maltodextrin placebo for 3 weeks. At baseline and after the intervention, participants will complete a "Fran" test, which involves performing sets of repeated dumbbell thrusters alternating with chin-ups. The performance measure is the time to complete the test. During the test, respiratory exchange ratio will be assessed to indirectly assess acidosis.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Minimum of one year of CrossFit experience and doing CrossFit training at least twice a week

Exclusion criteria

  • Having consumed beta-alanine in the past six months
  • Having changed the dose of any other nutritional supplement within the past month
  • Having suffered a major physical injury in the past six months

Treatment and study plan

Beta-alanine

Dietary Supplement

Beta-alanine

Maltodextrin

Dietary Supplement

Maltodextrin

Primary outcomes

  1. Change from baseline in time to perform a "Fran" CrossFit workout

    Time frame: Baseline, 3 weeks

    This involves alternating sets of dumbbell thrusters and pull-uips

Secondary outcomes

  1. Change from baseline in respiratory exchange ratio

    Time frame: Baseline, 3 weeks

    Respiratory exchange ratio (carbon dioxide exhaled relative to oxygen consumed) during the performance test

Sponsors and collaborators

Lead sponsor

University of Saskatchewan

Other

Registry information

Official study title

Examining the Effects of 3-weeks Beta-Alanine Supplementation on CrossFit® Performance

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Mar 17, 2023
Registry last updated
May 29, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.